HOPCo, founded in 1996 and headquartered in Phoenix, AZ, operates the nation's largest orthopedic value-based care organization. The company runs musculoskeletal (MSK) health outcomes management, service line transformation, and practice management solutions across more than 30 states, with additional offices in Fort Lauderdale, London, and Amsterdam. It is led by orthopedic physicians and seasoned healthcare executives.
The threat model here is financial and operational: MSK care is one of the highest-cost verticals in U.S. healthcare, and the data layer underneath it is fragmented across payer contracts, clinical outcomes, and utilization patterns. HOPCo's medical economics and analytics platform sits at that intersection, ingesting claims and clinical data to model cost trajectories and intervention leverage points. The MSK value-based care models and population health programs built on top of that platform are designed to shift orthopedic care from fee-for-service volume to outcomes-driven contracts with health systems.
On the technical side, the work spans medical economics and analytics, population health program design, and the modeling infrastructure that underpins full MSK value-based care arrangements with national health systems. Turn-key solutions package these capabilities for large health systems looking to restructure their musculoskeletal service lines. The scale - multi-state operations, multi-country presence - means the data pipelines and analytics stack handle heterogeneous payer, clinical, and operational datasets at volume.
HIPAA-regulated data is the baseline. The real complexity is in reconciling financial models, clinical outcomes metrics, and population health risk across payer types and geographies - then surfacing that to physicians and executives in ways that actually change care delivery decisions.
